innovation competition using the geography of Chinese internet penetration and Chinese import data. Increases in the ability of … from China impact U.S. innovation through the markets for innovation and existing products. We identify shocks to … rate, consistent with increased intellectual property competition …

at which they upgrade the quality of their products. We analyze the effect of import competition on quality upgrading …

How does competition affect innovation and how it is financed in R&D-intensive firms? We study the interaction between … competition, R&D investments, and the financing choices of such firms using data on biopharmaceutical firms. To motivate the … existing assets are all determined in response to the degree of competition in the industry. The key predictions are that, as …

. Here we explore the importance within the biotechnology industry of the non-financial metrics firms used to convey value … was a change over time in the importance of various metrics in determining the value of a biotechnology firm. We find that … value. Our results also suggest that the biotechnology regime changed and the Nobel Prize lost its luster as a signal of …

The biotechnology industry has been an engine of innovation for the U.S. healthcare system and, more generally, the U … North American Industry Classification System (NAICS) as biotechnology firms to estimate several Fama-French three factor …In the current study we find that biotechnology firms are exposed to greater financial risk than other industries and …

-effective source of capital but as a cross between selling a now-proven innovation and winning a lottery. Unlike most empirical IPO …

, such as intellectual human capital, can predict where and when biotechnology enterprises emerge and agglomerate. Density … dependence and previous founding dependence proxy many underlying processes; the legitimation and competition interpretation is … more conjectural than empirically tenable. We argue and demonstrate for biotechnology that an alternative model based on …

In this paper, we examine the determinants of control rights in technology strategic alliances between biotechnology … firms and pharmaceutical corporations, as well as with other biotechnology firms. We undertake three clinical studies and an …